FPH
03/09/2014 12:55
RELINT
REL: 1255 HRS Fisher & Paykel Healthcare Corporation Limited
RELINT: FPH: Disclosure of Directors and Officers Relevant Interests
A Details of director or officer
Name of director or officer of public issuer: Deborah Anne BAILEY
Name of public issuer: Fisher & Paykel Healthcare Corporation Limited
Name of related body corporate (if applicable): Not Applicable
Position held in public issuer: Vice President Human Resources
B Securities in public issuer or any related body corporate in which director
or officer has relevant interest
Number, class, and type of securities "i) 21,000 options to acquire ordinary
shares
ii) 8,000 Performance Share Rights"
C Nature of relevant interest and name of registered holder
Nature of relevant interest in securities Beneficial Ownership
Name of registered holder of securities Deborah Anne BAILEY
D Details of acquisitions and disposals
If the relevant interest was acquired--
Date of acquisition 28 August 2014
Consideration paid from acquisition NZ$Nil
If the relevant interest was disposed of--
Date of disposal Not applicable
Consideration paid for disposal Not applicable
Type of transaction
Describe the arrangement pursuant to which, or the circumstances in which,
the acquisition took place "i) Issue of 21,000 options to acquire ordinary
shares
ii) Issue of 8,000 Performance Share Rights"
E Total number of transactions this notice relates to Two
F Date of last disclosure notice (whether in form 1 or form 2) by the
director or officer 20 June 2014
A Details of director or officer
Name of director or officer of public issuer: Lewis George GRADON
Name of public issuer: Fisher & Paykel Healthcare Corporation Limited
Name of related body corporate (if applicable): Not Applicable
Position held in public issuer: Senior VP Products & Technology
B Securities in public issuer or any related body corporate in which director
or officer has relevant interest
Number, class, and type of securities "i) 80,000 options to acquire
ordinary shares
ii) 30,000 Performance Share Rights"
C Nature of relevant interest and name of registered holder
Nature of relevant interest in securities Beneficial Ownership
Name of registered holder of securities Lewis George GRADON
D Details of acquisitions and disposals
If the relevant interest was acquired--
Date of acquisition 28 August 2014
Consideration paid for acquisition NZ$Nil
If the relevant interest was disposed of--
Date of disposal Not Applicable
Consideration paid for disposal Not Applicable
Type of transaction
Describe the arrangement pursuant to which, or the circumstances in which,
the acquisition took place "i) Issue of 80,000 options to acquire ordinary
shares
ii) Issue of 30,000 Performance Share Rights"
E Total number of transactions this notice relates to Two
F Date of last disclosure notice (whether in form 1 or form 2) by the
director or officer 25 June 2014
A Details of director or officer
Name of director or officer of public issuer: Paul ANDREASSI
Name of public issuer: Fisher & Paykel Healthcare Corporation Limited
Name of related body corporate (if applicable): Not Applicable
Position held in public issuer: Vice President Quality & Regulatory
B Securities in public issuer or related body corporate to which this
disclosure relates
Number, class, and type of securities: "i) 32,000 options to acquire
ordinary shares
ii) 12,000 Performance Share Rights"
C Nature of relevant interest and name of registered holder
Nature of relevant interest in securities: Beneficial interest
Name of registered holder of securities Paul ANDREASSI
D Details of acquisitions and disposals
If the relevant interest was acquired--
Date of acquisition: 28 August 2014
Consideration paid for acquisition: NZ$Nil
If the relevant interest was disposed of--
Date of disposal: Not Applicable
Consideration paid for disposal: Not Applicable
Type of transaction
Describe the arrangement pursuant to which, or the circumstances in which,
the acquisition took place: "i) Issue of 32,000 options to acquire ordinary
shares
ii) Issue of 12,000 Performance Share Rights"
E Total number of transactions this notice relates to: Two
F Date of last disclosure notice (whether in form 1 or form 2) by the
director or officer: 4 August 2014
A Details of director or officer
Name of director or officer of public issuer: Paul Nigel SHEARER
Name of public issuer: Fisher & Paykel Healthcare Corporation Limited
Name of related body corporate (if applicable): Not Applicable
Position held in public issuer: Senior VP Sales & Marketing
B Securities in public issuer or any related body corporate in which director
or officer has relevant interest
Number, class, and type of securities "i) 80,000 options to acquire ordinary
shares
ii) 30,000 Performance Share Rights"
C Nature of relevant interest and name of registered holder
Nature of relevant interest in securities Beneficial Ownership
Name of registered holder of securities Paul Nigel SHEARER
D Details of acquisitions and disposals
If the relevant interest was acquired--
Date of acquisition 28 August 2014
Consideration paid from acquisition NZ$Nil
If the relevant interest was disposed of--
Date of disposal Not Applicable
Consideration received from disposal Not Applicable
Type of transaction
Describe the arrangement pursuant to which, or the circumstances in which,
the acquisition took place "i) Issue of 80,000 options to acquire ordinary
shares
ii) Issue of 30,000 Performance Share Rights"
E Total number of transactions this notice relates to Two
F Date of last disclosure notice (whether in form 1 or form 2) by the
director or officer 20 June 2014
A Details of director or officer
Name of director or officer of public issuer: Antony George BARCLAY
Name of public issuer: Fisher & Paykel Healthcare Corporation Limited
Name of related body corporate (if applicable): Not Applicable
Position held in public issuer: Chief Financial Officer & Company Secretary
B Securities in public issuer or related body corporate to which this
disclosure relates
Number, class, and type of securities: "i) 52,000 options to acquire
ordinary shares
ii) 20,000 Performance Share Rights"
C Nature of relevant interest and name of registered holder
Nature of relevant interest in securities: Beneficial Ownership
Name of registered holder of securities Antony George BARCLAY
D Details of acquisitions and disposals
If the relevant interest was acquired--
Date of acquisition: 28 August 2014
Consideration paid for acquisition: NZ$Nil
If the relevant interest was disposed of--
Date of disposal Not applicable
Consideration paid for disposal Not applicable
Type of transaction
Describe the arrangement pursuant to which, or the circumstances in which,
the acquisition took place: "i) Issue of 52,000 options to acquire ordinary
shares
ii) Issue of 20,000 Performance Share Rights"
E Total number of transactions this notice relates to: Two
F Date of last disclosure notice (whether in form 1 or form 2) by the
director or officer: 3 September 2014
A Details of director or officer
Name of director or officer of public issuer: Winston FONG
Name of public issuer: Fisher & Paykel Healthcare Corporation Limited
Name of related body corporate (if applicable): Not Applicable
Position held in public issuer: Vice President ICT
B Securities in public issuer or related body corporate to which this
disclosure relates
Number, class, and type of securities: "i) 23,000 options to acquire
ordinary shares
ii) 9,000 Performance Share Rights"
C Nature of relevant interest and name of registered holder
Nature of relevant interest in securities: Beneficial Ownership
Name of registered holder of securities Winston FONG
D Details of acquisitions and disposals
If the relevant interest was acquired--
Date of acquisition: 28 August 2014
Consideration paid for acquisition: NZ$Nil
If the relevant interest was disposed of--
Date of disposal: Not Applicable
Consideration paid for disposal: Not Applicable
Type of transaction
Describe the arrangement pursuant to which, or the circumstances in which,
the acquisition took place: "i) Issue of 23,000 options to acquire ordinary
shares
ii) Issue of 9,000 Performance Share Rights"
E Total number of transactions this notice relates to: Two
F Date of last disclosure notice (whether in form 1 or form 2) by the
director or officer: 11 July 2014
A Details of director or officer
Name of director or officer of public issuer: Michael Grenfell DANIELL
Name of public issuer: Fisher & Paykel Healthcare Corporation Limited
Name of related body corporate (if applicable): Not Applicable
Position held in public issuer: Managing Director/Chief Executive Officer
B Securities in public issuer or any related body corporate in which director
or officer has relevant interest
Number, class, and type of securities: Ordinary shares and options to
acquire ordinary shares
C Nature of relevant interest and name of registered holder
Nature of relevant interest in securities: Beneficial Ownership
Name of registered holder of securities Michael Grenfell DANIELL
D Details of acquisitions and disposals
If the relevant interest was acquired--
Date of acquisition 4 June 2014
Consideration paid for acquisition $Nil
If the relevant interest was disposed of--
Date of cancellation: 4 June 2014
Consideration received for cancellation: $Nil
Type of transaction
Describe the arrangement pursuant to which, or the circumstances in which,
the acqusition or disposal took place: Cancellation of 160,000 FPH options
and issue of 24,320 ordinary shares
E Total number of transactions this notice relates to: One
F Date of last disclosure notice (whether in form 1 or form 2) by the
director or officer: 20 December 2013
End CA:00254811 For:FPH Type:RELINT Time:2014-09-03 12:55:06